Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
The Journal of Infectious Diseases
|
August 2, 2025
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Pneumonia Hospitalization Among Medicare Beneficiaries Aged ≥65 in Long-Term Care
Lindsay Zielinski, Kristin Andrejko, Nong Shang, et al.
American Journal of Epidemiology
|
September 9, 2004
Added epidemiologic value to tuberculosis prevention and control of the investigation of clustered genotypes of Mycobacterium tuberculosis isolates
Scott J N McNabb, J Steve Kammerer, Andrew C Hickey, et al.
Health Services Research and Managerial Epidemiology
|
August 13, 2020
Pneumonia Hospitalization Coding Changes Associated With Transition From the 9th to 10th Revision of <i>International Classification of Diseases</i>
Ryan B Smithee, Tiffanie M Markus, Elizabeth Soda, et al.
AIDS (London, England)
|
February 18, 2015
Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis
Taraz Samandari, Tefera B Agizew, Samba Nyirenda, et al.
Open Forum Infectious Diseases
|
November 25, 2024
Impact of the US Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccination Program on Preventing Pertussis in Infants 2 to <6 Months of Age: A Case-Control Evaluation
Tami H Skoff, Amy B Rubis, Pam Daily Kirley, et al.
JAMA
|
January 21, 2022
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Emma K Accorsi, Amadea Britton, Katherine E Fleming-Dutra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 9, 2016
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada
Ruth N Moro, Andrey S Borisov, Jussi Saukkonen, et al.
JAMA
|
May 13, 2022
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance
Katherine E Fleming-Dutra, Amadea Britton, Nong Shang, et al.
The New England Journal of Medicine
|
May 25, 2022
Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron
Emma K Accorsi, Amadea Britton, Nong Shang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 14, 2017
Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation
Tami H Skoff, Amy E Blain, James Watt, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
The Journal of Infectious Diseases
|
August 2, 2025
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Pneumonia Hospitalization Among Medicare Beneficiaries Aged ≥65 in Long-Term Care
Lindsay Zielinski, Kristin Andrejko, Nong Shang, et al.
American Journal of Epidemiology
|
September 9, 2004
Added epidemiologic value to tuberculosis prevention and control of the investigation of clustered genotypes of Mycobacterium tuberculosis isolates
Scott J N McNabb, J Steve Kammerer, Andrew C Hickey, et al.
Health Services Research and Managerial Epidemiology
|
August 13, 2020
Pneumonia Hospitalization Coding Changes Associated With Transition From the 9th to 10th Revision of <i>International Classification of Diseases</i>
Ryan B Smithee, Tiffanie M Markus, Elizabeth Soda, et al.
AIDS (London, England)
|
February 18, 2015
Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis
Taraz Samandari, Tefera B Agizew, Samba Nyirenda, et al.
Open Forum Infectious Diseases
|
November 25, 2024
Impact of the US Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccination Program on Preventing Pertussis in Infants 2 to <6 Months of Age: A Case-Control Evaluation
Tami H Skoff, Amy B Rubis, Pam Daily Kirley, et al.
JAMA
|
January 21, 2022
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Emma K Accorsi, Amadea Britton, Katherine E Fleming-Dutra, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 9, 2016
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada
Ruth N Moro, Andrey S Borisov, Jussi Saukkonen, et al.
JAMA
|
May 13, 2022
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance
Katherine E Fleming-Dutra, Amadea Britton, Nong Shang, et al.
The New England Journal of Medicine
|
May 25, 2022
Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron
Emma K Accorsi, Amadea Britton, Nong Shang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 14, 2017
Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation
Tami H Skoff, Amy E Blain, James Watt, et al.
Page
of 5